<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04991597</url>
  </required_header>
  <id_info>
    <org_study_id>LESB 001</org_study_id>
    <nct_id>NCT04991597</nct_id>
  </id_info>
  <brief_title>The Effects of Injection Site Cooling and Solution Buffering on Perceived Pain During Local Anesthesia Administration</brief_title>
  <official_title>The Effects of Injection Site Cooling and Solution Buffering on Perceived Pain During Local Anesthesia Administration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nicholas Bastidas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants will have local anesthesia administered to the palmar aspect of both forearms&#xD;
      using 4 different injection methods in order to determine which method provides the best&#xD;
      results in terms of perceived pain, overall comfort, and participant preference. Injection&#xD;
      site cooling and solution buffering using a 3:1 ratio will be compared to the current&#xD;
      standard, no injection site cooling and 9:1 solution buffering.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Palmar aspect of participants forearms will be randomized to have either a cold compress pack or a room temperature compress pack placed on it. The cold compress pack serves as the trial intervention and the room temperature compress pack serves as the placebo. Each forearm will then be injected with both a 3:1 (experimental ratio) and a 9:1 (standard ratio) mixture of lidocaine with epinephrine:sodium bicarbonate in a randomized order.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will be blind to the solution ratio of each injection, injector will not be blind to solution to ensure safety.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain from Needle Insertion</measure>
    <time_frame>2 Months</time_frame>
    <description>Pain from needle insertion during each injection will be scored on a 0 - 10 scale by participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain from Solution Deposition</measure>
    <time_frame>2 Months</time_frame>
    <description>Pain from solution deposition during each injection will be scored on a 0 - 10 scale by participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Comfort Level During Injection</measure>
    <time_frame>2 Months</time_frame>
    <description>Comfort level during each injection will be scored on a 0 - 10 scale by participants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Injection Method Preference</measure>
    <time_frame>2 Months</time_frame>
    <description>Participants will select which of the 4 injection methods they preferred</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Buffered Anesthetic Solution pH</measure>
    <time_frame>2 Months</time_frame>
    <description>pH of each solution will be measured using a calibrated pH probe</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Left Forearm Injection Sites Cooled, Right Forearm Injection Sites at Room Temperature</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Palmar aspect of participants left forearm will have a cold compress pack placed on it. The palmar aspect of the right forearm will have a room temperature compress pack placed on it. Each forearm will be injected with 1mL of lidocaine with epinephrine buffered with sodium bicarbonate. Each forearm will be injected once with the experimental ratio (3:1) and once with the standard control ratio (9:1). Injections will be administered in a randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right Forearm Injection Sites Cooled, Left Forearm Injection Sites at Room Temperature</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Palmar aspect of participants right forearm will have a cold compress pack placed on it. The palmar aspect of the left forearm will have a room temperature compress pack placed on it. Each forearm will be injected with 1mL of lidocaine with epinephrine buffered with sodium bicarbonate. Each forearm will be injected once with the experimental ratio (3:1) and once with the standard control ratio (9:1). Injections will be administered in a randomized order.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cold Compress Pack</intervention_name>
    <description>Palmar aspect of forearm will have a cold compress pack placed on it.</description>
    <arm_group_label>Left Forearm Injection Sites Cooled, Right Forearm Injection Sites at Room Temperature</arm_group_label>
    <arm_group_label>Right Forearm Injection Sites Cooled, Left Forearm Injection Sites at Room Temperature</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Room Temperature Compress Pack</intervention_name>
    <description>Palmar aspect of forearm will have a room temperature compress pack placed on it.</description>
    <arm_group_label>Left Forearm Injection Sites Cooled, Right Forearm Injection Sites at Room Temperature</arm_group_label>
    <arm_group_label>Right Forearm Injection Sites Cooled, Left Forearm Injection Sites at Room Temperature</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Epinephrine</intervention_name>
    <description>Lidocaine with epinephrine will be buffered 3:1 with sodium bicarbonate</description>
    <arm_group_label>Left Forearm Injection Sites Cooled, Right Forearm Injection Sites at Room Temperature</arm_group_label>
    <arm_group_label>Right Forearm Injection Sites Cooled, Left Forearm Injection Sites at Room Temperature</arm_group_label>
    <other_name>Lidocaine Epinephrine buffered with Sodium Bicarbonate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Epinephrine</intervention_name>
    <description>Lidocaine with epinephrine will be buffered 9:1 with sodium bicarbonate</description>
    <arm_group_label>Left Forearm Injection Sites Cooled, Right Forearm Injection Sites at Room Temperature</arm_group_label>
    <arm_group_label>Right Forearm Injection Sites Cooled, Left Forearm Injection Sites at Room Temperature</arm_group_label>
    <other_name>Lidocaine Epinephrine buffered with Sodium Bicarbonate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provision of signed and dated informed consent form&#xD;
&#xD;
          -  Stated willingness to comply with all study procedures&#xD;
&#xD;
          -  Any gender, aged 21 - 65&#xD;
&#xD;
          -  In good general health with no peripheral neuropathy or disorders that may produce&#xD;
             peripheral neuropathy such as uncontrolled diabetes mellitus&#xD;
&#xD;
          -  Healthy intact skin on the palmar aspect of both left and right forearms&#xD;
&#xD;
          -  Fluent in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current use of any medication&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Known allergic reactions to components of the local anesthetic such as sulfites&#xD;
&#xD;
          -  History of vasovagal response to venipuncture or vaccination&#xD;
&#xD;
          -  History of trauma to the forearms i.e., bone breaks, burns, deep lacerations&#xD;
&#xD;
          -  Decreased sensation to the palmar aspect of either forearm&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicholas Bastidas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwell Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose F Palacios, BS</last_name>
    <phone>3479650989</phone>
    <email>jpalacios2@northwell.edu</email>
  </overall_contact>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 3, 2021</study_first_submitted>
  <study_first_submitted_qc>August 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Northwell Health</investigator_affiliation>
    <investigator_full_name>Nicholas Bastidas</investigator_full_name>
    <investigator_title>Associate Professor of Plastic Surgery</investigator_title>
  </responsible_party>
  <keyword>Local Anesthesia</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>Bicarbonate</keyword>
  <keyword>Pain</keyword>
  <keyword>Buffering</keyword>
  <keyword>Injection Site Cooling</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

